LivingGLP1
Study S001975

Clinical and Economic Outcomes of Patients With Type 2 Diabetes Mellitus Initiating Bydureon and Glargine

Registration

Registration
NCT02843399
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
15498
Start
2016-08-15
Primary completion
2016-12-15
Lead sponsor
AstraZeneca
Conditions
Diabetes Mellitus Type 2
Results posted
FALSE

Registered primary outcomes

  • Diabetes-related HCRU/costs [Up to 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.